RecallRadar

FDA Device recall Z-0892-2022

First SIGN SARS-CoV-2 Antigen Test

On 2022-04-13 the FDA classified a Class II recall of First SIGN SARS-CoV-2 Antigen Test by Whpm, citing frm became aware that a customer complaint was reported to US FDA that SARS-CoV-2 Antigen Tests were sold domestically by a pharmacy in California. These Antigen Tests have not re….

Read the official FDA Device notice

AgencyFDA Device
Recall numberZ-0892-2022
ClassificationClass II
Statusterminated
Initiated2022-03-04
Published2022-04-13
Last updated2026-09-13 11:56 UTC
CompanyWhpm
DistributionCA, FL, LA, MA, TX

Product

First SIGN SARS-CoV-2 Antigen Test

Reason

Frm became aware that a customer complaint was reported to US FDA that SARS-CoV-2 Antigen Tests were sold domestically by a pharmacy in California. These Antigen Tests have not received FDA Emergency Use Authorization, nor have these tests been cleared or approved by FDA for commercial distribution in the U.S.

Identifiers

code_info
Model Number: FSSA-CK20 UDI Codes: None Lot Numbers: F0301214078; F1227210039; F0809210004; F0906210010; P02112…Model Number: FSSA-CK20 UDI Codes: None Lot Numbers: F0301214078; F1227210039; F0809210004; F0906210010; P0211214070; F0914210014; F1013210020; F1214210034; F0121220041;

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:56 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-0892-2022%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.